SUMOylation in Glioblastoma: A Novel Therapeutic Target
2019
Protein SUMOylation is a dynamic post-translational modification which is involved in a diverse set of physiologic processes throughout the cell. Of note, SUMOylation also plays a role in the pathobiology of a myriad of cancers, one of which is glioblastoma (GBM). Accordingly, herein, we review core aspects of SUMOylation as it relates to GBM and in so doing highlight putative methods/modalities capable of therapeutically engaging the pathway for treatment of this deadly neoplasm.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
120
References
6
Citations
NaN
KQI